After getting stay orders on the issues of FDC and CoPP, the pharma industry may once again move court for another stay, this time the industry is contemplating to move court against the DCGI Dr Surinder Singh's practice of including several old drugs in the New Drugs List which prevents the manufacturers from getting licences from the state drug authorities.
The details can be read here.
No comments:
Post a Comment